Recent News

• 11.24.2025 - Landmark CREST-2 Study Published in the New England Journal of Medicine
• 11.23.2025 - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 11.19.2025 - InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
• 11.04.2025 - InspireMD Reports Third Quarter 2025 Financial Results
• 11.03.2025 - InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
• 10.21.2025 - InspireMD to Announce Third Quarter 2025 Financial Results

Recent Filings

• 11.18.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.10.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.07.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.04.2025 - EX-99.1 EX-99.1